These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32856039)

  • 1. Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts.
    Zhang C; Chen T; Li Z; Liu A; Xu Y; Gao Y; Xu D
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32856039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
    Zhao HB; Zeng YR; Han ZD; Zhuo YJ; Liang YK; Hon CT; Wan S; Wu S; Dahl D; Zhong WD; Wu CL
    Cancer Sci; 2021 Oct; 112(10):4365-4376. PubMed ID: 34252262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of Gene Expression Through One-Class Logistic Regression Machine Learning Identifies Stemness Features in Multiple Myeloma.
    Ban C; Yang F; Wei M; Liu Q; Wang J; Chen L; Lu L; Xie D; Liu L; Huang J
    Front Genet; 2021; 12():666561. PubMed ID: 34484287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD).
    Liu S; Yu Y; Xu J; Wang Y; Li D
    Cell Biol Int; 2024 Aug; 48(8):1169-1184. PubMed ID: 38818762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy.
    Wang Y; Ma L; He J; Gu H; Zhu H
    Front Immunol; 2024; 15():1464698. PubMed ID: 39267762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
    Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
    Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression.
    Wang J; Ying L; Xiong H; Zhou DR; Wang YX; Che HL; Zhong ZF; Wu GS; Ge YJ
    Front Immunol; 2024; 15():1460915. PubMed ID: 39351232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma.
    Lian H; Han YP; Zhang YC; Zhao Y; Yan S; Li QF; Wang BC; Wang JJ; Meng W; Yang J; Wang QH; Mao WW; Ma J
    Mol Oncol; 2019 Oct; 13(10):2227-2245. PubMed ID: 31385424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets.
    Zhang M; Chen H; Liang B; Wang X; Gu N; Xue F; Yue Q; Zhang Q; Hong J
    Front Mol Biosci; 2021; 8():777921. PubMed ID: 34938774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
    Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
    Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of lncRNA/Pseudogene-miRNA Network Based on In Silico Approaches for Glycolysis Pathway to Identify Prostate Adenocarcinoma-Related Potential Biomarkers.
    Khorsand M; Mostafavi-Pour Z; Tahmasebi A; Omidvar Kordshouli S; Mousavi P
    Appl Biochem Biotechnol; 2024 Apr; 196(4):2332-2355. PubMed ID: 37542606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis of GFAP as a Potential Key Regulator in Different Immune Phenotypes of Prostate Cancer.
    Yao W; Li X; Jia Z; Gu C; Jin Z; Wang J; Yuan B; Yang J
    Biomed Res Int; 2021; 2021():1466255. PubMed ID: 34222466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy.
    Wang Y; Li C; He J; Zhao Q; Zhou Y; Sun H; Zhu H; Ding B; Ren M
    Front Immunol; 2024; 15():1426474. PubMed ID: 38947325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging cell death patterns to predict metastasis in prostate adenocarcinoma and targeting PTGDS for tumor suppression.
    Chen B; Guo L; Wang L; Wu P; Zheng X; Tan C; Xie N; Sun X; Zhou M; Huang H; Hao N; Lei Y; Yan K; Wu D; Du Y
    Sci Rep; 2024 Sep; 14(1):21680. PubMed ID: 39289451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
    Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
    JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.